Dermira Inc (DERM)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre

Cours de l'action
Code mnémonique : DERM Marché : NSM


Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités
• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette Résultats financiers
Résultats financiers
 
Value bought

90 derniers jours

 
Value sold

90 derniers jours

 
Net insiders buying

90 derniers jours

 
Trades (buy and sell)

90 derniers jours

Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur Détails
2020-02-20 2020-02-20 A Achat

Bald Eagle Acquisition Corp

Actionnaire important
40 926 025 +100.0%
18,75
767 362 969 USD 		40 926 025 +100.0% 18,75 767 362 969 USD
2019-12-26 2019-12-24 VP Vente planifiée

Fust Matthew K

3 000 -37.3%
15,00
45 000 USD 		3 000 -37.3% 15,00 45 000 USD
2019-12-13 2019-12-12 VP Vente planifiée

Fust Matthew K

3 000 -27.1%
12,00
36 000 USD 		3 000 -27.1% 12,00 36 000 USD
2019-09-16 2019-09-12 V Vente

Fust Matthew K

6 000 -35.2%
8,77
52 636 USD 		6 000 -35.2% 8,77 52 636 USD
2019-08-19 2019-08-19 A Achat

WIGGANS THOMAS G

CEO & Chairman of the Board
23 419 +44.6%
8,54
199 998 USD 		23 419 +44.6% 8,54 199 998 USD
2019-08-19 2019-08-19 V Vente

Pena Luis C.

Chief Development Officer
23 419 -57.6%
8,54
199 998 USD 		23 419 -57.6% 8,54 199 998 USD
2019-04-09 2019-04-08 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
35 000 -79.7%
15,00
525 000 USD 		35 000 -79.7% 15,00 525 000 USD
2018-10-19 2018-10-19 VP Vente planifiée

Fust Matthew K

4 000 -22.2%
13,75
55 000 USD 		4 000 -22.2% 13,75 55 000 USD
2018-07-09 2018-07-09 AP Achat planifié

WIGGANS THOMAS G

CEO & Chairman of the Board
12 000 +17.8%
10,00
119 951 USD 		12 000 +17.8% 10,00 119 951 USD
2018-07-02 2018-07-02 AP Achat planifié

WIGGANS THOMAS G

CEO & Chairman of the Board
13 780 +25.6%
8,71
119 998 USD 		13 780 +25.6% 8,71 119 998 USD
2018-06-25 2018-06-25 AP Achat planifié

WIGGANS THOMAS G

CEO & Chairman of the Board
12 150 +29.2%
9,84
119 586 USD 		12 150 +29.2% 9,84 119 586 USD
2018-06-18 2018-06-18 AP Achat planifié

WIGGANS THOMAS G

CEO & Chairman of the Board
11 875 +40.0%
10,10
119 954 USD 		11 875 +40.0% 10,10 119 954 USD
2018-03-06 2018-03-02 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
2 500 -47.2%
25,00
62 500 USD 		2 500 -47.2% 25,00 62 500 USD
2018-03-02 2018-03-01 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
500 -15.1%
25,32
12 658 USD 		500 -15.1% 25,32 12 658 USD
2018-03-02 2018-03-01 VP Vente planifiée

Cohen David E

600 -2.0%
25,85
15 510 USD 		600 -2.0% 25,85 15 510 USD
2018-02-02 2018-02-01 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
3 000 -51.7%
28,55
85 642 USD 		3 000 -51.7% 28,55 85 642 USD
2018-02-02 2018-02-01 VP Vente planifiée

Cohen David E

600 -1.9%
28,87
17 322 USD 		600 -1.9% 28,87 17 322 USD
2018-01-04 2018-01-02 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
100 -3.4%
28,03
2 803 USD 		100 -3.4% 28,03 2 803 USD
2018-01-04 2018-01-02 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
2 900 -50.0%
27,04
78 407 USD 		2 900 -50.0% 27,04 78 407 USD
2018-01-04 2018-01-02 VP Vente planifiée

Cohen David E

600 -1.9%
28,03
16 818 USD 		600 -1.9% 28,03 16 818 USD
2018-01-04 2018-01-02 VP Vente planifiée

Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
200 -0.5%
27,91
5 581 USD 		200 -0.5% 27,91 5 581 USD
2018-01-04 2018-01-02 VP Vente planifiée

Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
18 258 -29.6%
27,04
493 773 USD 		18 258 -29.6% 27,04 493 773 USD
2017-12-20 2017-12-18 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
3 000 -43.9%
27,34
82 011 USD 		3 000 -43.9% 27,34 82 011 USD
2017-12-15 2017-12-13 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
5 000 -26.8%
27,51
137 566 USD 		5 000 -26.8% 27,51 137 566 USD
2017-12-05 2017-12-01 VP Vente planifiée

Cohen David E

600 -1.9%
25,49
15 294 USD 		600 -1.9% 25,49 15 294 USD
2017-11-03 2017-11-02 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
5 000 -27.1%
27,52
137 608 USD 		5 000 -27.1% 27,52 137 608 USD
2017-11-03 2017-11-01 VP Vente planifiée

Cohen David E

600 -1.8%
26,82
16 092 USD 		600 -1.8% 26,82 16 092 USD
2017-10-13 2017-10-11 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
7 500 -21.8%
30,04
225 300 USD 		7 500 -21.8% 30,04 225 300 USD
2017-10-11 2017-10-10 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
5 000 -27.1%
27,52
137 606 USD 		5 000 -27.1% 27,52 137 606 USD
2017-10-03 2017-10-02 VP Vente planifiée

Cohen David E

600 -1.8%
26,99
16 194 USD 		600 -1.8% 26,99 16 194 USD
2017-09-19 2017-09-18 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
9 500 -41.4%
27,51
261 336 USD 		9 500 -41.4% 27,51 261 336 USD
2017-09-05 2017-09-01 VP Vente planifiée

Cohen David E

600 -1.8%
23,56
14 136 USD 		600 -1.8% 23,56 14 136 USD
2017-08-29 2017-08-28 VP Vente planifiée

Cohen David E

600 -1.7%
23,81
14 286 USD 		600 -1.7% 23,81 14 286 USD
2017-08-14 2017-08-14 A Achat

CRAVES FRED B

10 000 +50.0%
23,95
239 460 USD 		10 000 +50.0% 23,95 239 460 USD
2017-08-14 2017-08-10 A Achat

CRAVES FRED B

20 000 +inf%
22,57
451 470 USD 		20 000 +inf% 22,57 451 470 USD
2017-08-02 2017-08-01 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
500 -6.1%
27,58
13 791 USD 		500 -6.1% 27,58 13 791 USD
2017-07-06 2017-07-05 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
2 500 -6.8%
30,00
75 008 USD 		2 500 -6.8% 30,00 75 008 USD
2017-07-05 2017-07-03 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
5 000 -39.4%
29,06
145 298 USD 		5 000 -39.4% 29,06 145 298 USD
2017-06-21 2017-06-20 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
2 500 -6.3%
30,01
75 032 USD 		2 500 -6.3% 30,01 75 032 USD
2017-06-05 2017-06-02 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
1 121 -12.7%
27,61
30 951 USD 		1 121 -12.7% 27,61 30 951 USD
2017-06-05 2017-06-01 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
3 879 -33.5%
27,50
106 673 USD 		3 879 -33.5% 27,50 106 673 USD
2017-05-16 2017-05-15 VP Vente planifiée

Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
1 312 -2.8%
27,07
35 516 USD 		1 312 -2.8% 27,07 35 516 USD
2017-05-03 2017-05-01 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
2 500 -6.0%
33,65
84 116 USD 		2 500 -6.0% 33,65 84 116 USD
2017-05-03 2017-05-01 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
100 -1.5%
34,39
3 439 USD 		100 -1.5% 34,39 3 439 USD
2017-05-03 2017-05-01 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
7 900 -54.6%
33,65
265 833 USD 		7 900 -54.6% 33,65 265 833 USD
2017-05-03 2017-05-01 VP Vente planifiée

RINGO WILLIAM R

500 -100.0%
34,06
17 030 USD 		500 -100.0% 34,06 17 030 USD
2017-04-18 2017-04-17 VP Vente planifiée

Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
1 303 -2.8%
33,97
44 267 USD 		1 303 -2.8% 33,97 44 267 USD
2017-04-04 2017-04-03 VP Vente planifiée

RINGO WILLIAM R

500 -100.0%
34,03
17 015 USD 		500 -100.0% 34,03 17 015 USD
2017-04-04 2017-04-03 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
1 414 -17.9%
34,03
48 118 USD 		1 414 -17.9% 34,03 48 118 USD
2017-04-04 2017-04-03 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
6 586 -45.5%
33,38
219 831 USD 		6 586 -45.5% 33,38 219 831 USD
2017-04-04 2017-04-03 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
521 -1.2%
34,03
17 730 USD 		521 -1.2% 34,03 17 730 USD
2017-04-04 2017-04-03 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
1 979 -4.4%
33,40
66 106 USD 		1 979 -4.4% 33,40 66 106 USD
2017-03-16 2017-03-15 VP Vente planifiée

Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
100 -0.2%
36,37
3 637 USD 		100 -0.2% 36,37 3 637 USD
2017-03-16 2017-03-15 VP Vente planifiée

Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
1 203 -2.6%
35,74
42 993 USD 		1 203 -2.6% 35,74 42 993 USD
2017-03-07 2017-03-03 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
4 000 -38.2%
37,60
150 416 USD 		4 000 -38.2% 37,60 150 416 USD
2017-03-02 2017-03-01 VP Vente planifiée

RINGO WILLIAM R

500 -100.0%
35,09
17 547 USD 		500 -100.0% 35,09 17 547 USD
2017-03-02 2017-03-01 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
100 -0.2%
35,89
3 589 USD 		100 -0.2% 35,89 3 589 USD
2017-03-02 2017-03-01 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
400 -0.9%
34,49
13 795 USD 		400 -0.9% 34,49 13 795 USD
2017-03-02 2017-03-01 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
1 200 -2.6%
33,81
40 569 USD 		1 200 -2.6% 33,81 40 569 USD
2017-03-02 2017-03-01 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
800 -1.7%
32,60
26 079 USD 		800 -1.7% 32,60 26 079 USD
2017-03-02 2017-03-01 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
272 -4.0%
35,91
9 769 USD 		272 -4.0% 35,91 9 769 USD
2017-03-02 2017-03-01 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
600 -8.2%
35,08
21 047 USD 		600 -8.2% 35,08 21 047 USD
2017-03-02 2017-03-01 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
4 328 -37.1%
33,91
146 782 USD 		4 328 -37.1% 33,91 146 782 USD
2017-03-02 2017-03-01 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
5 800 -33.2%
32,99
191 347 USD 		5 800 -33.2% 32,99 191 347 USD
2017-02-16 2017-02-15 VP Vente planifiée

Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
403 -0.9%
31,38
12 646 USD 		403 -0.9% 31,38 12 646 USD
2017-02-16 2017-02-15 VP Vente planifiée

Griffith Christopher M.

SVP Head Corp. Dev. & Strategy
900 -1.9%
30,52
27 472 USD 		900 -1.9% 30,52 27 472 USD
2017-02-16 2017-02-15 VP Vente planifiée

RINGO WILLIAM R

500 -100.0%
32,00
16 000 USD 		500 -100.0% 32,00 16 000 USD
2017-02-15 2017-02-14 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
1 505 -3.1%
30,00
45 153 USD 		1 505 -3.1% 30,00 45 153 USD
2017-02-03 2017-02-01 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
204 -3.1%
29,99
6 118 USD 		204 -3.1% 29,99 6 118 USD
2017-02-03 2017-02-01 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
4 796 -41.8%
29,33
140 647 USD 		4 796 -41.8% 29,33 140 647 USD
2017-02-02 2017-02-01 VP Vente planifiée

BAUER EUGENE A

Chief Medical Officer
995 -2.0%
30,00
29 852 USD 		995 -2.0% 30,00 29 852 USD
2017-01-19 2017-01-17 VP Vente planifiée

Griffith Christopher M.

VP Corp. Dev. & Strategy
200 -0.4%
30,08
6 016 USD 		200 -0.4% 30,08 6 016 USD
2017-01-19 2017-01-17 VP Vente planifiée

Griffith Christopher M.

VP Corp. Dev. & Strategy
1 103 -2.4%
28,94
31 921 USD 		1 103 -2.4% 28,94 31 921 USD
2017-01-05 2017-01-04 VP Vente planifiée

WIGGANS THOMAS G

CEO & Chairman of the Board
3 000 -31.7%
32,51
97 543 USD 		3 000 -31.7% 32,51 97 543 USD
2017-01-04 2017-01-04 VP Vente planifiée

RINGO WILLIAM R

500 -100.0%
32,00
16 000 USD 		500 -100.0% 32,00 16 000 USD
// ... existing code ... // ... rest of the file ...